NASDAQ: TSBX
Turnstone Biologics Corp Stock Ownership - Who owns Turnstone Biologics?

Insider buying vs selling

Have Turnstone Biologics Corp insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when TSBX insiders and whales buy or sell their stock.

TSBX Shareholders

What type of owners hold Turnstone Biologics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Davis Jerel14.61%3,381,692$1.13MInsider
Versant Ventures V LLC14.61%3,381,692$1.13MInsider
Orbimed Advisors LLC13.39%3,099,265$1.04MInsider
Rishi Gupta13.39%3,099,265$1.04MInsider
Orbimed Advisors LLC13.39%3,099,265$1.04MInstitution
Fmr LLC4.90%1,133,987$379.89kInsider
Fmr LLC4.90%1,133,987$379.89kInstitution
Bml Capital Management LLC4.77%1,103,386$369.63kInstitution
Pfm Health Sciences LP4.03%932,348$312.34kInstitution
Takeda Pharmaceutical Co Ltd3.87%895,824$300.10kInstitution

1 of 3

TSBX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TSBX42.44%57.56%
HCWB53.40%46.60%Net BuyingNet Buying
SLXN2.72%66.15%
SNSE7.59%71.61%Net Selling
CHRO9.03%54.19%Net Buying

Turnstone Biologics Stock Ownership FAQ

Who owns Turnstone Biologics?

Turnstone Biologics (NASDAQ: TSBX) is owned by 44.91% institutional shareholders, 60.91% Turnstone Biologics insiders, and 0.00% retail investors. Davis Jerel is the largest individual Turnstone Biologics shareholder, owning 3.38M shares representing 14.61% of the company. Davis Jerel's Turnstone Biologics shares are currently valued at $1.13M.

If you're new to stock investing, here's how to buy Turnstone Biologics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.